DV
Dividend Vision

OKYO — OKYO Pharma Ltd ADR

OKYO Pharma Ltd ADR (OKYO)

Total return is -58.0% over the past 4.2 years, 159.4 points behind SPY at 101.4%. Its deepest 1-year drawdown was 55.9%.

This is a single-stock equity holding in OKYO Pharma Ltd, a pharmaceutical company traded via American Depositary Receipts (ADRs). The fund does not currently pay distributions and carries no publicly available expense ratio or significant assets under management. This holding appeals primarily to investors with direct interest in the company's equity performance rather than those seeking dividend income.

OKYO key facts

Asset type
Stock
Asset class
Equity
Inception date
05/17/2022
Last close
$1.52
Market cap
$75,570,128
Average volume
65000.0
Beta
0.045
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.24